The Effects of Treatment on Hematological Parameters in the Patients with Acne Vulgaris

Year 2021, Volume: 8 Issue: 3, 204 - 206, 28.12.2021

Ercan Saruhan Emine Tuğba Alataş

https://doi.org/10.47572/muskutd.872846

Abstract

Acne vulgaris is a multifactorial disease of the pilosebaceous unit. Various immunological and inflammatory factors play a role with different pathophysiological mechanisms in the development of acne vulgaris by increasing sebum production. The aim of this study was to reveal the changes in CBC sub-parameters and calculated parameters before and after acne vulgaris treatment and to enable these parameters to be used as non-invasive, low-cost, effective new laboratory tests in the evaluation of treatment efficacy. A total of 162 patients (109 females, 67.3%; 53 males, 32.7%) were included in this study. In this study, it was found that NEU, MPV, P-LCR, and PDW levels decreased significantly after treatment (p<0.001). There was a significant decrease in NLR and PLR values (p<0.001). LYM and PLT count increased significantly after the treatment (p<0.001). CBC parameters such as NLR, PLR, and P-LCR can be used to evaluate the efficacy of systemic isotretinoin treatment in patients with acne vulgaris. 

Keywords

Acne Vulgaris, Inflammation, Neutrophil to Lymphocyte Ratio, Platelet

Akne Vulgaris Hastalarında Tedavinin Hematolojik Parametreler Üzerine Etkisi

Abstract

Akne vulgaris pilosebase ünitenin multifaktöriyel inflamatuvar hastalığıdır. Akne vulgaris gelişiminde çeşitli immünolojik ve inflamatuar faktörler farklı patofizyolojik mekanizmalarla sebum üretimini artırarak rol oynamaktadır. Bu çalışmanın amacı, akne vulgaris tedavi öncesi ve sonrası hemogram parametrelerinde meydana gelen değişiklikleri ortaya koymak ve bu parametrelerin tedavinin değerlendirilmesinde etkinliğini araştırmaktır. Çalışmaya 162 hasta (109 kadın, 67.3%; 53 erkek, 32.7%) dahil edildi. Çalışma sonucunda NEU, MPV, P-LCR ve PDW düzeylerinin tedavi sonrasında anlamlı derecede azaldığı saptandı (p<0.001). NLR ve PLR değerlerinde de tedavi sonrası anlamlı bir düşüş görüldü (p<0.001). LYM ve PLT sayısının ise tedavi sonrası arttığı görüldü (p<0.001). Akne vulgarisli hastalarda sistemik izotretinoin tedavisini değerlendirmede NLR, PLR ve P-LCR gibi hemogram parametreleri etkin şekilde kullanılabilir. 

Keywords

Akne Vulgaris, İnflamasyon, Nötrofil/Lenfosit Oranı, Platelet

References

• 1. Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet. 2012;379(9813):361-72.
• 2. Rapp DA, Brenes GA, Feldman SR, et al. Anger and acne: implications for quality of life, patient satisfaction and clinical care. Br J Dermatol. 2004;151(1):183-9.
• 3. Tom WL, Friedlander SF. Acne through the ages: case-based observations through childhood and adolescence. Clin Pediatr (Phila). 2008;47(7):639-51.
• 4. Tanghetti EA. The role of inflammation in the pathology of acne. J Clin Aesthet Dermatol. 2013;6(9):27-35.
• 5. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(1):1-37.
• 6. Oeff MK, Seltmann H, Hiroi N, et al. Differential Regulation of Toll-Like Receptor and CD14 Pathways by Retinoids and Corticosteroids in Human Sebocytes. Dermatology. 2006;213(3):266.
• 7. Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945-73.
• 8. Oge LK, Broussard A, Marshall MD. Acne Vulgaris: Diagnosis and Treatment. Am Fam Physician. 2019;100(8):475-84.
• 9. Bray C, Bell LN, Liang H, et al. Erythrocyte Sedimentation Rate and C-reactive Protein Measurements and Their Relevance in Clinical Medicine. Wmj. 2016;115(6):317-21.
• 10. Cataudella E, Giraffa CM, Di Marca S, et al. Neutrophil-To-Lymphocyte Ratio: An Emerging Marker Predicting Prognosis in Elderly Adults with Community-Acquired Pneumonia. J Am Geriatr Soc. 2017;65(8):1796-801.
• 11. Katsambas A, Papakonstantinou A. Acne: Systemic treatment. Clin Dermatol. 2004;22(5):412-8.
• 12. Imtiaz F, Shafique K, Mirza SS, et al. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med. 2012;5(1):2-6.
• 13. Abd-Elmaged WM, Nada EA, Hassan MH, et al. Lesional and circulating levels of interleukin-17 and 25-hydroxycholecalciferol in active acne vulgaris: Correlation to disease severity. J Cosmet Dermatol. 2019;18(2):671-6.
• 14. Gencoglan G, Inanir I, Miskioglu M, et al. Evaluation of sequential effect of isotretinoin on the haematological parameters in patients with acne vulgaris. Cutan Ocul Toxicol. 2018;37(2):139-42.
• 15. Turkmen D, Altunisik N, Sener S. Investigation of monocyte HDL ratio as an indicator of inflammation and complete blood count parameters in patients with acne vulgaris. Int J Clin Pract. 2020;74(12):e13639.
• 16. Seçkin HY, Baş Y, Takçı Z, et al. Effects of isotretinoin on the inflammatory markers and the platelet counts in patients with acne vulgaris. Cutan Ocul Toxicol. 2016;35(2):89-91.
• 17. Önder S, Ozturk M. Can monocyte/HDL show inflammatory activity of isotretinoin treatment in acne patients? Cutan Ocul Toxicol. 2020;39(2):111-4.
• 18. Kutlu Ö. Effect of isotretinoin treatment on the inflammatory markers in patients with acne vulgaris: can monocyte/HDL be a new indicator for inflammatory activity of isotretinoin treatment? Cutan Ocul Toxicol. 2020;39(1):67-70.
• 19. Milner JD, Ward JM, Keane-Myers A, et al. Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2-associated inflammatory disease. Proceedings of the National Academy of Sciences. 2007;104(2):576-81.
• 20. Metin N, Turan Ç. Increases in uric acid and monocyte-high-density lipoprotein ratio as possible atherosclerotic indicators in acne patients using isotretinoin. J Cosmet Dermatol. 2021.
• 21. Jansen T, Altmeyer P. Thrombocytosis induced by low-dose isotretinoin. Int J Dermatol. 2000;39(12):956-7.
• 22. Moeller KE, Touma SC. Prolonged Thrombocytopenia Associated with Isotretinoin. Annals of Pharmacotherapy. 2003;37(11):1622-4.